The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma

PURPOSE: Inter-tumoral heterogeneity at the differential lesion level raises the possibility of distinct organ-specific responses to immune checkpoint inhibitors (ICIs). We aimed to comprehensively examine the clinicopathological factors to predict and assess the efficacy of nivolumab, programmed ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Han Sang, Kim, Chang Gon, Hong, Jung Yong, Kim, Il-hwan, Kang, Beodeul, Jung, Sanghoon, Kim, Chan, Shin, Sang Joon, Choi, Hye Jin, Cheon, Jaekyung, Chon, Hong Jae, Lim, Ho Yeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290164/
https://www.ncbi.nlm.nih.gov/pubmed/35860833
http://dx.doi.org/10.1177/17588359221113266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290164/
https://www.ncbi.nlm.nih.gov/pubmed/35860833
http://dx.doi.org/10.1177/17588359221113266

Ejemplares similares